Interventional cardiology & peripheral vascular devices market is driven by increasing count of aging population and rising demand for angioplasty procedures which are minimally invasive. Furthermore, technological enhancements in interventional cardiology & peripheral vascular devices is expected to boost the market growth. The application of preliminary conventional first-level medication and rising cases of product recall is expected to hinder the market growth. Demand of stents having bioabsorbable properties across emerging markets is anticipated to offer abundant growth opportunities. Irregularity in reimbursements along with entry barriers for new players are the key market challenges.
The market is segmented on the basis of types of devices, procedure and geography. On the basis of types, the market is segmented into angioplasty stents market and catheters market. On the basis of procedure, the market is segmented into endovascular aneurysm repair (EVAR), stent grafts market, inferior vena cava (IVC) filters market, plaque modification devices market, hemodynamic flow alteration devices market and accessories market. On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).
Key market players profiled in this report are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Cordis Corporation (A Subsidiary of Johnson & Johnson Co.), Medtronic, Inc., Spectranetics International BV, St. Jude Medical, Inc. and Terumo Corporation.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
Key Company Profile